Jounce Therapeutics Inc
(JNCE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,919 | -90,872 | -43,842 | 56,823 | -27,379 |
| Depreciation Amortization | 2,990 | 3,748 | 3,448 | 2,371 | 2,724 |
| Other Working Capital | 8,882 | -7,847 | 2,835 | -98,932 | -48,365 |
| Other Operating Activity | 10,170 | 11,477 | 9,771 | 9,609 | 9,407 |
| Operating Cash Flow | $-28,877 | $-83,494 | $-27,788 | $-30,129 | $-63,613 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,928 | -130,272 | -85,895 | -188,999 | -252,918 |
| PPE Investments | -919 | -373 | -94 | -985 | -1,359 |
| Sale Of Investment | 109,325 | 70,131 | 137,287 | 221,366 | 340,691 |
| Investing Cash Flow | $83,478 | $-60,514 | $51,298 | $31,382 | $86,414 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 442 | 92,044 | 70,742 | 4,082 | 1,546 |
| Financing Cash Flow | $442 | $92,044 | $70,742 | $4,082 | $1,546 |
| Beginning Cash Position | 96,799 | 148,763 | 54,511 | 49,176 | 24,829 |
| End Cash Position | 151,842 | 96,799 | 148,763 | 54,511 | 49,176 |
| Net Cash Flow | $55,043 | $-51,964 | $94,252 | $5,335 | $24,347 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,877 | -83,494 | -27,788 | -30,129 | -63,613 |
| Capital Expenditure | -919 | -373 | -94 | -985 | -1,359 |
| Free Cash Flow | -29,796 | -83,867 | -27,882 | -31,114 | -64,972 |